Study for the treatment of cardiovascular and kidney diseases

Are you

• a healthy male or infertile* female
• between 18 and 55 years (inclusive)
• with a BMI between 18 and 32 kg/m² (inclusive)
• who does not smoke or has stopped smoking at least 3 months before the screening visit (including nicotine containing products such as nicotine patches or electronic cigarettes)
• who does not use daily medication

* postmenopausal (no menstrual periods for at least 12 months) removal of the uterus, removal of both fallopian tubes, removal of both ovaries, or another medical cause

What does this trial involve? 

In study 2600398, SGS CPU is investigating the treatment of cardiovascular and kidney diseases. During +/- 8 weeks you will have the following appointments:

• a screening visit
• a stay of 4 days (3 nights) and a stay of 3 days (2 nights)
• 15 morning return visits
• an end of trial visit

Take part in this trial and

• contribute to the medicine of tomorrow
• a compensation will be provided

This study was approved by the competent Belgian health authorities and an independent ethics committee.

View information leaflet panel A

View study dates panel A